Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization

Abstract Nonalcoholic fatty liver disease (NAFLD), a major cause of chronic liver disorders, has become a serious public health issue. Although the Smad4 signaling pathway has been implicated in the progression of NAFLD, the specific role of Smad4 in hepatocytes in NAFLD pathogenesis remains unclear...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Yang, Xuanxuan Yan, Rui Chen, Xin Xin, Shuang Ge, Yongxiang Zhao, Xinlong Yan, Jinhua Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-025-07376-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571253127380992
author Wei Yang
Xuanxuan Yan
Rui Chen
Xin Xin
Shuang Ge
Yongxiang Zhao
Xinlong Yan
Jinhua Zhang
author_facet Wei Yang
Xuanxuan Yan
Rui Chen
Xin Xin
Shuang Ge
Yongxiang Zhao
Xinlong Yan
Jinhua Zhang
author_sort Wei Yang
collection DOAJ
description Abstract Nonalcoholic fatty liver disease (NAFLD), a major cause of chronic liver disorders, has become a serious public health issue. Although the Smad4 signaling pathway has been implicated in the progression of NAFLD, the specific role of Smad4 in hepatocytes in NAFLD pathogenesis remains unclear. Hepatocyte-specific knockout Smad4 mice (AlbSmad4−/−) were first constructed using the Cre-Loxp recombinant system to establish a high-fat diet induced NAFLD model. The role of Smad4 in the occurrence and development of NAFLD was determined by monitoring the body weight of mice, detecting triglycerides and free fatty acids in serum and liver tissue homogenates, staining the tissue sections to observe the accumulation of liver fat, and RT-qPCR detecting the expression of genes related to lipogenesis, fatty acid intake, and fatty acid β oxidation. The molecular mechanism of Smad4 in hepatocytes affecting NAFLD was therefore investigated through combining in vitro and in vivo experiments. Smad4 deficiency in hepatocytes mitigated NAFLD progression and decreased inflammatory cell infiltration. Moreover, Smad4 deficiency inhibited CXCL1 secretion by suppressing the activation of the ASK1/P38/JNK signaling pathway. Furthermore, targeting CXCL1 using CXCR2 inhibitors diminished hepatocyte lipogenesis and inhibited the polarization of M1-type macrophages. Collectively, these results suggested that Smad4 plays a vital role in exacerbating NAFLD and may be a promising candidate for anti-NAFLD therapy.
format Article
id doaj-art-9b32dda884c0406086ac9b100a5e86fc
institution Kabale University
issn 2041-4889
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-9b32dda884c0406086ac9b100a5e86fc2025-02-02T12:44:46ZengNature Publishing GroupCell Death and Disease2041-48892025-01-0116111110.1038/s41419-025-07376-8Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarizationWei Yang0Xuanxuan Yan1Rui Chen2Xin Xin3Shuang Ge4Yongxiang Zhao5Xinlong Yan6Jinhua Zhang7The College of Life Science and Bioengineering, Beijing Jiaotong UniversityThe College of Life Science and Bioengineering, Beijing Jiaotong UniversityThe College of Life Science and Bioengineering, Beijing Jiaotong UniversityThe College of Life Science and Bioengineering, Beijing Jiaotong UniversityNational Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targetubg Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-Targeting Theranostics, Guangxi Medical UniversityNational Center for International Research of Bio-Targeting Theranostics, Guangxi Key Laboratory of Bio-Targetubg Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Talent Highland of Bio-Targeting Theranostics, Guangxi Medical UniversityFaculty of Environmental and Life Sciences, Beijing University of TechnologyThe College of Life Science and Bioengineering, Beijing Jiaotong UniversityAbstract Nonalcoholic fatty liver disease (NAFLD), a major cause of chronic liver disorders, has become a serious public health issue. Although the Smad4 signaling pathway has been implicated in the progression of NAFLD, the specific role of Smad4 in hepatocytes in NAFLD pathogenesis remains unclear. Hepatocyte-specific knockout Smad4 mice (AlbSmad4−/−) were first constructed using the Cre-Loxp recombinant system to establish a high-fat diet induced NAFLD model. The role of Smad4 in the occurrence and development of NAFLD was determined by monitoring the body weight of mice, detecting triglycerides and free fatty acids in serum and liver tissue homogenates, staining the tissue sections to observe the accumulation of liver fat, and RT-qPCR detecting the expression of genes related to lipogenesis, fatty acid intake, and fatty acid β oxidation. The molecular mechanism of Smad4 in hepatocytes affecting NAFLD was therefore investigated through combining in vitro and in vivo experiments. Smad4 deficiency in hepatocytes mitigated NAFLD progression and decreased inflammatory cell infiltration. Moreover, Smad4 deficiency inhibited CXCL1 secretion by suppressing the activation of the ASK1/P38/JNK signaling pathway. Furthermore, targeting CXCL1 using CXCR2 inhibitors diminished hepatocyte lipogenesis and inhibited the polarization of M1-type macrophages. Collectively, these results suggested that Smad4 plays a vital role in exacerbating NAFLD and may be a promising candidate for anti-NAFLD therapy.https://doi.org/10.1038/s41419-025-07376-8
spellingShingle Wei Yang
Xuanxuan Yan
Rui Chen
Xin Xin
Shuang Ge
Yongxiang Zhao
Xinlong Yan
Jinhua Zhang
Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
Cell Death and Disease
title Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
title_full Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
title_fullStr Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
title_full_unstemmed Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
title_short Smad4 deficiency in hepatocytes attenuates NAFLD progression via inhibition of lipogenesis and macrophage polarization
title_sort smad4 deficiency in hepatocytes attenuates nafld progression via inhibition of lipogenesis and macrophage polarization
url https://doi.org/10.1038/s41419-025-07376-8
work_keys_str_mv AT weiyang smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT xuanxuanyan smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT ruichen smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT xinxin smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT shuangge smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT yongxiangzhao smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT xinlongyan smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization
AT jinhuazhang smad4deficiencyinhepatocytesattenuatesnafldprogressionviainhibitionoflipogenesisandmacrophagepolarization